New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 25, 2014
08:18 EDTBCS, AZNAstraZeneca, Barclays investors push back on executive pay, Telegraph says
38.5% of AstraZeneca (AZN) shareholders voted against the company's executive pay plan, while 24% of investors voted against Barclays' (BCS) pay plan, reported The Telegraph. "We are disappointed with today's vote. As a priority we will be seeking to understand what concerns lay behind this," said an AstraZeneca spokesman. Reference Link
News For AZN;BCS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 9, 2015
09:28 EDTBCSBarclays appoints Ben Davey investment bank CSO, Bloomberg says
Barclays has named Ben Davey chief strategy officer of the investment bank in London, Bloomberg reports, citing an internal memo. Davey will join the Investment Bank Executive Committee and report to securities unit CEO Tom King, the report says. Most recently, Davey served as head of the financial institutions group for banking in Europe, the Middle East, and Africa, the report says. Reference Link
08:24 EDTAZNAstraZeneca temporarily stops two cancer drug trials, Bloomberg says
AstraZeneca has temporarily stopped two cancer drug combination trials as a result of reports of lung disease, Bloomberg reports, citing an email from spokeswoman Esra Erkal-Paler. The company halted the tests that combined its AZD9291 compound with durvalumab for patients with non-small cell lung cancer after a rise in the incidence of lung disease-like reports, the report says. Patients enrolled in the trials will receive new consent forms to help them understand the new information and can decide whether to follow through with the trials, the report says. Reference Link
October 8, 2015
08:05 EDTAZNAstraZeneca says study reveals burden of severe RSV in preterm infants
Subscribe for More Information
07:25 EDTBCSRosenblatt to hold a conference
8th Annual Global Exchange Leader Conference is being held in New York on October 8.
October 7, 2015
10:58 EDTBCSBarclays to launch Apple Pay support in UK in early 2016
Barclays (BCS) plans to launch Apple (AAPL) Pay support in the UK in early 2016, reports Mac Rumors. In an email to customer Mike Jobson, Barclays CEO of Personal and Corporate Banking Ashok Vaswani said, "We have signed up for ApplePay and will launch it very early in the New Year. We truly value your custom and hope that you continue to bank with us particularly since we are launching this shortly." Reference Link
October 6, 2015
13:32 EDTAZNBiotechs plummet with TPP seen as industry negative
Biotechs are falling intraday after reports that the Trans-Pacific Partnership, or TPP, has language that the exclusivity period for bioligics, or drugs derived from a biological sources, would be eight years, less than the twelve years it is currently in the United States. WHAT'S NOTABLE: In the U.S., biologics are protected from competition by follow-on products for twelve years from the time they are first granted marketing approval by the U.S. Food and Drug Administration, a protection that is distinct from patent protection. Recent reports on the TPP suggest that the protection will last five years with an additional safety monitoring period of up to three years before a biosimilar can be registered, which would effectively be an eight year exclusivity period. ANALYST REACTION: Piper Jaffray analyst Joshua Schimmer, however, said the development is a "step forward," especially since it does not overrule the 12 years' exclusivity for the drugs in the U.S. While the sector asked for twelve years' exclusivity to match the U.S., eight years is a "reasonable compromise," the analyst argued. His top picks were Alexion (ALXN), Celgene (CELG), and Amgen (AMGN) in the large-cap space, GW Pharmaceuticals (GWPH) and bluebird bio (BLUE) among mid-caps, and Flex Pharma (FLKS), Lion Biotechnologies (LBIO), Otonomy (OTIC), and Ignyta (RXDX) in the small-cap sector. Further, Schimmer stated that more names look "increasingly compelling" amid the selloff. NOTABLE DECLINERS: Alexion is lower by 2.53%, Celgene is down 4.32%, Amgen is declining 1.91%, Biogen (BIIB) is down 3.4%, and Gilead Sciences (GILD) is falling 2.22%. STOCKS TO WATCH: Other publicly traded companies in the pharmaceutical space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
October 5, 2015
07:19 EDTBCSOpen Mobile Media to hold a summit
Subscribe for More Information
October 1, 2015
19:10 EDTBCSJPMorgan to pay $595M in credit-default swap suit, Bloomberg says
JPMorgan (JPM) is set to pay $595M to settle allegations that major banks as well as Markit (MRKT) colluded to control information in the credit-default swaps market, reports Bloomberg, citing people briefed on the matter. Morgan Stanley (MS), Barclays (BCS), and Goldman Sachs (GS) will pay a respective $230M, $175M, and $164M, sources told Bloomberg. Reference Link
07:31 EDTAZNLeerink to hold a roundtable
Subscribe for More Information
07:28 EDTBCSSEC Commissioner calls for increased transparency for dark pools, Reuters says
Subscribe for More Information
September 30, 2015
08:02 EDTAZNAstraZeneca says SYMBICORT results published in journal
Subscribe for More Information
September 29, 2015
17:50 EDTBCSBarclays to exit Bmarkets business, Reuters says
Subscribe for More Information
08:07 EDTAZNAstraZeneca says Brilinta 60-mg tablets now available in U.S. pharmacies
Subscribe for More Information
September 28, 2015
07:52 EDTAZNIIR Holdings to hold a conference
Subscribe for More Information
07:14 EDTBCSBarclays could sell parts of investment banking unit in Brazil, Sky News reports
Barclays is examining a sale of parts of its investment banking business in Brazil, Sky News reports. According to sources, discussions with prospective buyers of the Barclays assets are currently at a "preliminary" stage. Reference Link
06:20 EDTBCSCOMCO probing UBS, Julius Baer for metals market price fixing, AFP reports
Subscribe for More Information
September 25, 2015
07:22 EDTAZNEuropean Society for Medical Oncology to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use